Verenium is an industrial biotechnology company engaged in the development and commercialization of enzymes for industrial processes in North America, Europe, South America, and Asia. The company manufactures and markets its proprietary enzyme products in the fields of animal health and nutrition, grain processing, oilfield services, and other industrial processes, such as pulp and paper and textiles. For more information visit the company’s Web site at www.ir.verenium.com
Let us hear your thoughts below:
The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
